FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmacy, pharmacology and medicine. What is presented is using N-(2-adamantyl)-hexamethylenimine hydrochloride (Gimantan) as an analgecis and anti-inflammatory agent.
EFFECT: increasing a pain limit in rats and anti-exudate activity; unlike sodium diclofenac, gimantan has shown no ulcerogenic action.
7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION IN GEL MEDICINAL FORM FOR LOCAL USE ON THE BASIS OF N-(2-ADAMANTIL)-HEXAMETHYLENEMINE HYDROCHLORIDE | 2017 |
|
RU2663452C1 |
| MEANS FOR REDUCING ALCOHOL MOTIVATION IN ALCOHOL DEPENDENCE | 2014 |
|
RU2582966C2 |
| MEDICATION FOR TREATING CEREBRAL CIRCULATION DISORDERS AND BRAIN TRAUMAS | 2012 |
|
RU2554502C9 |
| MEANS FOR OPIOID ABSTINENCE SYNDROME ARRESTING | 2017 |
|
RU2643588C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING PHYSIOLOGICALLY ACTIVE HEPTAPEPTIDES, HAVING ANTISPASMODIC, ANXIOLYTIC, CENTRAL ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY, AS WELL AS ANTI-ALCOHOL ACTIVITY | 2012 |
|
RU2506269C1 |
| AGENT WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY, ANTI-INFLAMMATORY AND ANTIALLERGIC ACTION | 2018 |
|
RU2686672C1 |
| AGENT FOR CORRECTING AUTISM SPECTRUM DISORDERS | 2017 |
|
RU2666598C1 |
| ANALGESIC AGENT FOR VISCERAL PAIN MANAGEMENT | 2010 |
|
RU2429874C1 |
| NEW BIOLOGICALLY ACTIVE COMPOUND N-[3-(4-NITROPHENYLAMINO)-INDOL-2-YLMETHYLENE]AMINOGUANIDINE HYDROCHLORIDE WITH ANTIINFLAMMATORY ACTIVITY | 2010 |
|
RU2478618C2 |
| INJECTABLE DOSAGE FORM FOR TREATMENT OF PARKINSON'S DISEASE, METHOD FOR PREPARING AND USING IT | 2011 |
|
RU2520758C2 |
